SCHEMBL3086740

SCHEMBL3086740

NS(=O)(=O)N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10478911 0.70 CA1 (0.46)
SCHEMBL3278397 0.70
SCHEMBL10478906 0.70 CA1 (0.46)
SCHEMBL339328 0.67
SCHEMBL2784628 0.67
SCHEMBL13787346 0.67
SCHEMBL8155164 0.67
SCHEMBL25534 0.65
Sulfamide SCHEMBL5880 0.65
Sulfamate SCHEMBL10424181 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109020922-B Preparation method of cyclic sulfonamide compound 陕西师范大学 2022-01-04 CN disclosed
CN-112969688-A Fungicidal nitroaniline substituted pyrazoles FMC公司 2021-06-15 CN disclosed
CN-112702913-A Controlled release formulations for agrochemicals 拜耳公司 2021-04-23 CN disclosed
CN-110770232-A Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro-and dihydrofurancarboxylic acids and esters 拜耳公司 2020-02-07 CN disclosed
US-9125856-B1 Method of stabilizing human eye tissue THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-09-08 US disclosed
US-8466203-B2 Method of stabilizing human eye tissue by reaction with nitrite and related agents such as nitro compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-06-18 US disclosed
US-20100173019-A1 METHOD OF STABILIZING HUMAN EYE TISSUE BY REACTION WITH NITRITE AND RELATED AGENTS SUCH AS NITRO COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-07-08 US disclosed
WO-2008070185-A2 METHOD OF STABILIZING HUMAN EYE TISSUE BY REACTION WITH NITRITE AND RELATED AGENTS SUCH AS NITRO COMPOUNDS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-06-12 WO disclosed
US-20070032537-A1 5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases ARENA PHARMACEUTICALS, INC. (US) 2007-02-08 US disclosed
EP-1633351-A1 5-SUBSTITUTED 2H-PYRAZOLE-3-CARBOXYLIC ACID DERIVATIVES AS AGONISTS FOR THE NICOTINIC ACID RECEPTOR RUP25 FOR THE TREATMENT OF DYSLIPIDEMIA AND RELATED DISEASES Arena Pharmaceuticals, Inc. (US) 2006-03-15 EP disclosed
WO-2005011677-A1 5-SUBSTITUTED 2H-PYRAZOLE-3-CARBOXYLIC ACID DERIVATIVES AS AGONISTS FOR THE NICOTINIC ACID RECEPTOR RUP25 FOR THE TREATMENT OF DYSLIPIDEMIA AND RELATED DISEASES ARENA PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed
US-5356999-A Contains an ethylene-propylene copolymer which has been grafted with an unsaturated reactive monomer and thereafter with amines containing sulfonamide units; lubricating oil additive TEXACO INC. (US) 1994-10-18 US disclosed
US-4496514-A REACTION INJECTION MOLDING THE B. F. GOODRICH COMPANY (US) 1985-01-29 US disclosed
US-4400490-A REACTION INJECTION MOLDING OF A LACTAM AND EPOXY COMPOUND; IMPACT STRENGTH THE B.F. GOODRICH COMPANY (US) 1983-08-23 US disclosed
EP-0085324-A2 Nylon compositions and rim process for making same The B.F. GOODRICH Company (US) 1983-08-10 EP disclosed